Quantbot Technologies’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-353
Closed -$29K 1486
2024
Q2
$29K Sell
353
-780
-69% -$84.3K ﹤0.01% 1312
2024
Q1
$164K Buy
+1,133
New +$95.7K 0.01% 1058
2022
Q1
Sell
-684
Closed -$451K 1676
2021
Q4
$451K Buy
684
+393
+135% +$300K 0.04% 560
2021
Q3
$244K Buy
+291
New +$295K 0.02% 772
2021
Q2
Sell
-1,133
Closed -$1.24M 1486
2021
Q1
$1.24M Buy
1,133
+1,054
+1,334% +$1.39M 0.12% 249
2020
Q4
$112K Buy
+79
New +$84.3K 0.01% 726
2020
Q3
Sell
-452
Closed -$316K 1319
2020
Q2
$316K Buy
452
+101
+29% +$58.3K 0.04% 327
2020
Q1
$122K Buy
+351
New +$249K 0.08% 292

Other funds holding CDLX

Quantbot Technologies's CDLX Position: Q3 2024 in Review

Quantbot Technologies sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 353 shares — an estimated $29K sold.

Quantbot Technologies first reported a position in CDLX in Q1 2020 and held it in 8 quarters. The position peaked at $1.24M in Q1 2021. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • Quantbot Technologies reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
  • Quantbot Technologies sold 353 Cardlytics shares in Q3 2024, an estimated $29K.
  • Quantbot Technologies first reported a position in Cardlytics in Q1 2020 and held it in 8 quarters.
  • Quantbot Technologies's Cardlytics position peaked at $1.24M in Q1 2021.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on Quantbot Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.